A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
A phase 2 trial of Linperlisib in Follicular lymphoma, run by Shanghai YingLi Pharmaceutical Co. Ltd., with a status the registry has not verified recently.
Overview
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma is a phase 2 interventional study registered as NCT04379167 by Shanghai YingLi Pharmaceutical Co. Ltd., with 140 participants planned, started 2020-12-30 and due to reach its primary completion in 2022-12-30. Interventions recorded: YY-20394. Conditions recorded: Follicular Lymphoma.
Linked to the drug Linperlisib because the registry names it among its interventions and Follicular lymphoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialEfficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Shares Linperlisib and the tag pipeline.
- TrialPhase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
Shares Follicular lymphoma and the tag pipeline.
- TrialA Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Shares Follicular lymphoma and the tag pipeline.
- TrialMIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma
Shares Follicular lymphoma and the tag pipeline.
- TrialA Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
Shares Follicular lymphoma and the tag pipeline.
- TrialDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Shares Follicular lymphoma and the tag pipeline.
- TreatmentTC011
Shares Follicular lymphoma and the tag pipeline.
- TrialStudy to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Shares Follicular lymphoma and the tag pipeline.